Edison Scientific Announces Agreement with Pfizer to Accelerate Research and DevelopmentBusiness Wire • 10/29/26
Exploring Analyst Estimates for Pfizer (PFE) Q3 Earnings, Beyond Revenue and EPSZacks Investment Research • 10/29/26
Obesity Pipeline vs. COVID Drag: The Hidden Numbers Deciding Pfizer's Q3 Fate on Nov. 324/7 Wall Street • 10/29/26
Pfizer Cancer Therapy Shows Extended Progression-Free Survival in Multiple Myeloma PatientsBenzinga • 10/27/26
Pfizer (PFE) Expected to Beat Earnings Estimates: Should You Buy?Zacks Investment Research • 10/27/26
Pfizer's ELREXFIO Outperforms Standard Regimens and Meets Primary Endpoint in Phase 3 Study in Relapsed or Refractory Multiple MyelomaBusiness Wire • 10/27/26
Pfizer's TALZENNA Plus XTANDI FDA-Approved for an Earlier Metastatic Prostate Cancer Treatment SettingBusiness Wire • 10/26/26
Moderna Tumbles 7% as Cancer Vaccine Selloff Deepens; BioNTech Falls 3%, Pfizer Holds Steady24/7 Wall Street • 10/26/26
Buy 8 Barron's Big Better Bets (Than T-Bills) Out Of 14 'Safer' October DiviDogsSeeking Alpha • 10/25/26
Pfizer's 25-Valent Pediatric Pneumococcal Conjugate Vaccine Candidate Shows Robust Phase 2 Data at IDWeek 2026Business Wire • 10/24/26
Pfizer's Dividend Yield Is One of the Highest in the S&P 500. Here's Why the Dividend Is Safer Than It Might SeemThe Motley Fool • 10/24/26
Moderna Sinks 4% After 18% Plunge as Melanoma Vaccine Selloff Extends; Merck and Pfizer Slip24/7 Wall Street • 10/23/26
Moderna Tumbles 25% After Apparent Early Leak of Melanoma Vaccine Data; BioNTech Dips, Pfizer Edges Higher24/7 Wall Street • 10/22/26
Moderna Jumps 7% While Melanoma Vaccine Data Looms; Bristol Myers Squibb Rises 5%, Pfizer Inches Higher24/7 Wall Street • 10/20/26
Pfizer Inc. (PFE) Is a Trending Stock: Facts to Know Before Betting on ItZacks Investment Research • 10/20/26